Patents by Inventor Jonathan Uhr

Jonathan Uhr has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130075318
    Abstract: An apparatus for isolating rare cells from a blood sample is disclosed. The apparatus includes a reservoir for supplying the blood sample and a pump for receiving the blood sample. The apparatus also includes a microchip and a set of magnets. The microchip has a microchannel formed between the microchip and a glass slide. The microchannel is connected between the reservoir and the pump to allow the blood sample to flow from the reservoir to the pump. The set of magnets is located adjacent to the glass slide to form a magnetic gradient along the glass slide on which rare cells can be isolated from the blood sample.
    Type: Application
    Filed: September 23, 2011
    Publication date: March 28, 2013
    Inventors: Xiaojing Zhang, Yu-Yen Huang, Ting Shen, Kazunori Hoshino, Jonathan Uhr, Eugene Frenkel
  • Publication number: 20080112957
    Abstract: Anti-ErbB2 antibodies are described which bind to an epitope in Domain 1 of ErbB2 and induce cell death via apoptosis. Various uses for these antibodies are also described.
    Type: Application
    Filed: October 31, 2007
    Publication date: May 15, 2008
    Applicants: Board of Regents, The University of Texas System, Genentech, Inc.
    Inventors: Brian Fendly, Gail Phillips, Richard Scheuermann, Jonathan Uhr
  • Publication number: 20060099213
    Abstract: This invention discloses monoclonal antibodies (MAbs) which have little or no signaling activity as monomers become potent anti-tumor agents when they are converted into homoconjugates. The homoconjugates exert anti-growth activity by signaling G0/G1 arrest or apoptosis, depending upon which cell surface molecule they bind. This activity is specific and does not require an Fc portion. These conjugates are potent, anti-tumor agents.
    Type: Application
    Filed: April 8, 2002
    Publication date: May 11, 2006
    Applicant: Board of Regents, The University of Texas System
    Inventors: Maria-Ana Ghetie, Jonathan Uhr, Ellen Vitetta